News | Page 52 | Weill Department of Medicine

Dr. Martinez and Colleagues Discover No Benefit from NAC in Treating Deadly Lung Disease

Dr. Fernando Martinez, the newly appointed Executive Vice Chair of Medicine, Weill Cornell Department of Medicine, has published new findings in The New England Journal of Medicine on N-acetylcysteine (NAC), a widely used antioxidant for treating deadly lung disease. Along with senior author Dr. Ganesh Raghu and other colleagues, the 264-patient study determined that there is no evidence that NAC slowed the progression of idiopathic pulmonary fibrosis (IPF) or improved lung function.Related... Read More

Resident-in-Training Wins Prestigious Linda Dunbar Award for Population Health and Health System Transformation

Dr. Madeline SterlingMadeline Sterling, M.D., M.P.H., a PGY2 in the NYP/WCM internal medicine residency program, primary care track, has been selected by the Johns Hopkins GIM Housestaff Research Awards Review Committee to receive the inaugural Linda Dunbar Award for Population Health and Health System Transformation. The committee noted Dr. Sterling's "excellent" abstract, entitled "Predicting Early (30-Day) Readmissions Among Congestive Heart Failure Admissions: A Retrospective Analysis of... Read More

A Record Number of Superstars Selected in the Weill Department of Medicine

The Employee Recognition Review Committee (R3) of the Joan and Sanford I. Weill Department of Medicine completed its bimonthly review of all nominees and a record four superstar winners were announced, with two from the Division of Hematology and Medical Oncology ( Jessica Martinez, Senior Medical Secretary and Virginia Hernandez, Senior Clinical Technician), and Ericka Fong, Financial Coordinator (Division of Hospital Medicine), Donna Chambers, Credentialing Specialist (Division of Education... Read More

Dr. Abraham Begins Pivotal New Research on Racial/Ethnic Differences Regarding Virologic Failure in Patients with HIV/AIDS

Dr. Bisrat K. Abraham, a newly appointed Instructor of Medicine in infectious diseases at Weill Cornell Medicine, has recently begun a pivotal research project working with Dr. Roy Gulick, Chief of the Division of Infectious Diseases, Weill Department of Medicine. The project, which focuses on the racial differences in response to antiretroviral therapy for HIV infection, is supported by the NIH-funded ACTG (AIDS Clinical Trials Group). In the field of HIV patient care, racial/ethnic... Read More

Weill Cornell Names Its Department of Medicine for Joan and Sanford I. Weill

Two New Endowed Chairs EstablishedWeill Cornell Medical College has named its department of medicine the Joan and Sanford I. Weill Department of Medicine. The naming is in recognition of the Weills’ recent $100 million gift – which also established the Joan and Sanford I. Weill Center for Metabolic Health – and honors the couple’s longstanding dedication to the medical college. Additionally, two new endowed chairs have been established: Dr. Augustine M.K. Choi has been named the Sanford I.... Read More

Dr. Wolk Interviewed on Appropriate Use of Tests for Stable Coronary Artery Disease

Dr. Michael J. Wolk, Clinical Professor of Medicine, was interviewed on the appropriate use of advanced medical imaging and intervention on the detection and treatment of patients with stable coronary artery disease, which was published February 4th in the Journal of the American College of Cardiology. In over 90 clinical scenarios of patients commonly seen by physicians with possible coronary artery disease, nuclear imaging, echo, CTA, exercise stress testing, MR, and angiography were compared... Read More

Dr. Simon Publishes Paper in Transfusion on Tick-Borne Blood Infection Babesia

Dr. Matthew SimonMatthew S. Simon, M.D., M.S., Assistant Professor of Medicine (Division of Hospital Medicine), and colleagues, have published a research study on the cost-effectiveness of novel screening strategies for preventing transfusion-transmitted babesiosis, the most common red blood cell transfusion-transmitted infection in the United States. The results suggest that, in highly endemic states such as New York, screening donated blood for antibodies to Babesia, would avoid additional... Read More

Dr. Schafer Appointed to Director of the Richard T. Silver, M.D., Myeloproliferative Neoplasm Center

Dr. Andrew SchaferDr. Andrew I. Schafer, Professor of Medicine and former Chair of the department, has been named as Director of the Richard T. Silver, M.D., Myeloproliferative Neoplasm Center. A ceremony was held in February to dedicate the new center, which will further translational research and treatments in the field of myeloproliferative neoplasms (MPNs).Dr. Schafer is an expert in the research and treatment of MPNs and a world-renowned physician-scientist in hematology and medical... Read More

Dr. Furman Publishes Landmark Paper in NEJM: Pill Melts Away Chronic Lymphocytic Leukemia (CLL)

Dr. Richard Furman, Division of Hematology & Medical Oncology, and co-authors have published a landmark paper in the New England Journal of Medicine. Their results utilizing the drug, Idelalisib, in a randomized, double-blinded study (5 countries) suggest that a common form of leukemia may be treated without toxic chemotherapy.

Employee Recognition Program: Three Superstars Announced

The Employee Recognition Review Committee (R3) of the Joan and Sanford I. Weill Department of Medicine completed its bimonthly review of all nominees and three superstar winners were announced: Deanna Joa, Senior Medical Secretary (Hospital Medicine-Lower Manhattan), Anna Quinones, Senior Medical Secretary (Gastroenterology & Hepatology), and Susan Daniel, Clinical Technician (Pulmonary & Critical Care Medicine).Deanna Joa was highlighted for her technological prowess, cultural... Read More